T05

4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]sulfonyl}-2-(3-methylphenoxy)benzoic acid

Created:	2012-10-23
Last modified:	2012-10-26

Find Related PDB Entry
1 entries where T05 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	1
Bond Count	63
Aromatic Bond Count	12

2D diagram of T05

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-{[(3S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl]sulfonyl}-2-(3-methylphenoxy)benzoic acid
Systematic Name (OpenEye OEToolkits)	4-[(3S)-3-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]piperidin-1-yl]sulfonyl-2-(3-methylphenoxy)benzoic acid
Formula	C₂₄ H₂₅ N₃ O₇ S
Molecular Weight	499.536
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(c2cc(Oc1cc(ccc1)C)c(C(=O)O)cc2)N4CCCC(N3C=C(C(=O)NC3=O)C)C4
SMILES	CACTVS	3.370	Cc1cccc(Oc2cc(ccc2C(O)=O)[S](=O)(=O)N3CCC[CH](C3)N4C=C(C)C(=O)NC4=O)c1
SMILES	OpenEye OEToolkits	1.7.6	Cc1cccc(c1)Oc2cc(ccc2C(=O)O)S(=O)(=O)N3CCCC(C3)N4C=C(C(=O)NC4=O)C
Canonical SMILES	CACTVS	3.370	Cc1cccc(Oc2cc(ccc2C(O)=O)[S](=O)(=O)N3CCC[C@@H](C3)N4C=C(C)C(=O)NC4=O)c1
Canonical SMILES	OpenEye OEToolkits	1.7.6	Cc1cccc(c1)Oc2cc(ccc2C(=O)O)S(=O)(=O)N3CCC[C@@H](C3)N4C=C(C(=O)NC4=O)C
InChI	InChI	1.03	InChI=1S/C24H25N3O7S/c1-15-5-3-7-18(11-15)34-21-12-19(8-9-20(21)23(29)30)35(32,33)26-10-4-6-17(14-26)27-13-16(2)22(28)25-24(27)31/h3,5,7-9,11-13,17H,4,6,10,14H2,1-2H3,(H,29,30)(H,25,28,31)/t17-/m0/s1
InChIKey	InChI	1.03	HYOKWKXYBOKTDO-KRWDZBQOSA-N

Related Resource References

Resource Name	Reference
PubChem	66553127
ChEMBL	CHEMBL2331741

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.